FDA Label for Guaifenesin 600 Mg
View Indications, Usage & Precautions
- OTC - ACTIVE INGREDIENT SECTION
- OTC - PURPOSE SECTION
- INDICATIONS & USAGE SECTION
- OTC - DO NOT USE SECTION
- OTC - ASK DOCTOR SECTION
- OTC - STOP USE SECTION
- OTC - PREGNANCY OR BREAST FEEDING SECTION
- OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- DOSAGE & ADMINISTRATION SECTION
- STORAGE AND HANDLING SECTION
- INACTIVE INGREDIENT SECTION
- OTC - QUESTIONS SECTION
- PRINCIPAL DISPLAY PANEL
Guaifenesin 600 Mg Product Label
The following document was submitted to the FDA by the labeler of this product Marksans Pharma Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Otc - Active Ingredient Section
For 600 mg:
Active ingredient (in each extended-release tablet)
Guaifenesin, USP 600 mg
For 1200 mg:
Active ingredient (in each extended-release tablet)
Guaifenesin, USP 1200 mg
Otc - Purpose Section
Purpose
Expectorant
Indications & Usage Section
Uses
• helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Otc - Do Not Use Section
Do not use
• for children under 12 years of age
Otc - Ask Doctor Section
Ask a doctor before use if you have
• persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
• cough accompanied by too much phlegm (mucus)
Otc - Stop Use Section
Stop use and ask a doctor if
- cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
Otc - Pregnancy Or Breast Feeding Section
If pregnant or breast-feeding, ask a health professional before use.
Otc - Keep Out Of Reach Of Children Section
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Dosage & Administration Section
Directions
For 600 mg
• do not crush, chew, or break extended - release tablet
• take with a full glass of water
• this product can be administered without regard for the timing of meals
• adults and children 12 years of age and over: 1 or 2 extended - release tablets every 12 hours. Do not exceed 4 extended - release tablets in 24 hours.
• children under 12 years of age: do not use
For 1200 mg
• do not crush, chew, or break extended - release tablet
• take with a full glass of water
• this product can be administered without regard for the timing of meals
• adults and children 12 years of age and over: 1 extended - release tablet every 12 hours. Do not exceed 2 extended - release tablets in 24 hours.
• children under 12 years of age: do not use
Storage And Handling Section
Other information
• store at 20-25°C (68-77°F)
Inactive Ingredient Section
Inactive ingredients colloidal silicon dioxide, copovidone, FD&C Blue No. 1 Aluminum lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone (K-30), sodium starch glycolate, stearic acid
Otc - Questions Section
Questions or comments?
Call 1-877-376-4271 (weekdays 9 AM to 5 PM)
You may also report side effects to this phone number.
Manufactured for:
Time-Cap Labs, Inc.
7 Michael Avenue,
Farmingdale,
NY 11735, USA
Manufactured by:
Marksans Pharma Ltd.
Plot No. L-82, L-83
Verna Indl. Estate
Verna, Goa-403722, India
Principal Display Panel
NDC: 25000-042-55
Guaifenesin Extended-Release Tablets 600 mg
20's count (2 x 10's blister) Carton
NDC: 25000-042-01
Guaifenesin Extended-Release Tablets 600 mg
20's count Bottle Label
NDC: 25000-042-01
Guaifenesin Extended-Release Tablets 600 mg
20's count Bottle Carton
NDC: 25000-042-12
Guaifenesin Extended-Release Tablets 600 mg
500's count Bottle Label
NDC: 25000-041-75
Guaifenesin Extended-Release Tablets 1200 mg
12's count (2 x 6's blister) Carton
NDC: 25000-041-12
Guaifenesin Extended-Release Tablets 1200 mg
500's count Bottle Label
* Please review the disclaimer below.